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Abstract
Di-2-ethylhexyl terephthalate (DEHTP), a structural isomer of the plasticizer di-2-ethylhexyl 
phthalate (DEHP), is used in food packaging and medical devices, among other applications, and 
is a potential replacement for DEHP and other ortho-phthalate plasticizers. Identifying sensitive 
and specific biomarkers of DEHTP is necessary to assess humans’ background exposure to 
DEHTP. Using mass spectrometry, we investigated the metabolism of DEHTP by human liver 
microsomes to identify in vitro DEHTP metabolites. We unequivocally identified terephthalic acid 
(TPA) and mono-2-ethylhydroxyhexyl terephthalate (MEHHTP), using authentic standards, and 
tentatively identified mono-2-ethylhexyl terephthalate (MEHTP) and two other oxidative 
metabolites of DEHTP: mono-2-ethyloxohexyl terephthalate (MEOHTP), and mono-2-ethyl-5-
carboxypentyl terephthalate (MECPTP) from their mass spectrometry fragmentation patterns. We 
also evaluated the formation of in vitro metabolites of DEHP. DEHTP and DEHP produced 
similar metabolites, but their metabolite profiles differed considerably. DEHTP metabolized to 
form TPA, a metabolite of several terephthalates, as the major in vitro metabolite, followed by 
MEHTP, MEHHTP, MEOHTP and MECPTP. MEHTP, MEHHTP, MEOHTP and MECPTP, 
which are specific metabolites of DEHTP, may be suitable biomarkers for assessing exposure to 
DEHTP. Nonetheless, data on the urinary excretion fraction and temporal stability of these 
metabolites, among other considerations, are needed to demonstrate their utility as exposure 
biomarkers.
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Di-2-ethylhexyl terephthalate (DEHTP; Eastman 168™) is considered a safe alternative to 
its structural isomer, di-2-ethylhexyl phthalate (DEHP), a commonly used plasticizer 
(Barber, 1994; Barber and Topping, 1995; Gray et al., 2000). For example, animal studies 
suggested that perinatal exposure to DEHP but not DEHTP altered male sexual 
differentiation (Gray et al., 2000). Furthermore, there were no adverse effects from DEHTP 
on reproductive tissue, kidneys, liver hepatocytes, and peroxisomes, which are known 
targets of DEHP toxicity (Wirnitzer et al., 2011).
DEHTP is used as a plasticizer in flexible polyvinyl chloride, in toys and childcare articles, 
and in medical devices (Eastman Chemical Company, 2011). DEHTP has also Food Contact 
Notification clearance from the US Food & Drug Administration (Eastman Chemical 
Company, 2011) and also complies with the European Commission regulation for use in 
food contact applications (European Food Safety Authority, 2008).
The usage of DEHTP may be increasing as suggested by a study showing rising levels of 
DEHTP in dust samples of German households from 1997 to 2009 (Nagorka et al., 2011). 
However, data on human exposure to DEHTP do not exist. Studies to assess the extent of 
human exposure to DEHTP at environmental levels require the identification of sensitive 
and specific exposure biomarkers.
Rats dosed with 14C-DEHTP eliminated most of its radioactivity in feces as unchanged 
DEHTP and excreted smaller amounts of mono-2-ethylhexyl terephthalate (MEHTP), 
terephthalic acid (TPA) and other polar metabolites in urine (Barber et al., 1994). However, 
human metabolites of DEHTP are unknown. In vitro studies have been used to identify 
metabolites of xenobiotic chemicals (Moslemi et al., 1993; Muhitch, 1993; Treadway and 
Pelkonen, 2006; Zulalian et al., 1993) which can be used as biomarkers of exposure to these 
chemicals (Silva et al., 2013b).
In the present study, we used mass spectrometry to investigate the metabolism of DEHTP 
using human liver microsomes and to identify DEHTP exposure biomarkers for human 
biomonitoring. We also compared the in vitro metabolite profiles of DEHP and DEHTP.
2. Experimental
2.1. Reagents and standards
DEHTP, TPA, phthalic acid (PA), and 13C2-PA were purchased from Sigma–Aldrich (St. 
Louis, MO, USA). Mono-2-ethylhexyl phthalate (MEHP) and 13C4-MEHP were purchased 
from Cambridge Isotope laboratories (Andover, MA, USA). Mono-2-ethyl-5-carboxypentyl 
phthalate (MECPP), a specific isomer of mono-2-ethylhydroxyhexyl terephthalate 
(MEHHTP), namely mono-2-ethyl-5-hydroxyhexyl terephthalate, and 13C6-MECPP were 
purchased from CanSyn (Ontario, Canada). Mono-2-ethyl-5-hydroxyhexyl phthalate 
(MEHHP), mono-2-ethyl-5-oxohexyl phthalate (MEOHP), and their deuterated analogs 
were purchased from ADM (Teltow, Germany). The stock standard solutions were prepared 
in acetonitrile and the calibration standards were prepared in 10% acetonitrile in water (Silva 
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et al., 2007). All reagents, solvents and standard materials were used without further 
purification.
2.2. In vitro metabolism
In a 30 mL Qorpak™ Clear Wide Mouth French square bottle (Fisher Scientific, Pittsburg, 
PA, USA), a DEHTP standard solution (100 lL; 769.6 μg/mL) was mixed with pH 7.4 
phosphate buffer (0.1 M, 8 mL), water (1 mL), NADPH solution (A) (500 μL, BD 
Gentest™), NADPH solution (B) (100 μL BD Gentest™), and female human liver 
microsome homogenates (200 μL, BD Gentest™, Woburn, MA, USA). The bottle was 
capped and the contents were gently mixed and placed in an incubator (Fisher Scientific, 
Hampton, NH, USA) at 37 °C for 5 h. Aliquots of microsomal suspension (1 mL) were 
transferred into microcentrifuge tubes and vortex mixed, before being centrifuged at 12,500 
rpm for 20 min on an Avanti high performance centrifuge (Beckman Coulter Inc., Brea, CA, 
USA). The supernatant was transferred into autosampler vials for analysis. The above 
procedure was repeated without DEHTP, but with water (100 μL) for the preparation of the 
control samples.
For the time course study, DEHTP or DEHP standard solution (1000 μL; 250 μg/mL) was 
dried down to 100 μL under a stream of nitrogen and was mixed with pH 7.4 phosphate 
buffer (0.1 M, 7 mL), water (1 mL), NADPH solution (A) (600 μL), NADPH solution (B) 
(100 μL), and male human liver microsome homogenates (200 μL) in a 30 mL Qorpak™ 
Clear Wide Mouth French square bottle. The bottle was capped and the contents were gently 
mixed and placed in an incubator at 37 °C. At several time intervals between time 0 and 27 
h, 100 μL aliquots (N = 3) of microsomal suspension were withdrawn into microcentrifuge 
tubes containing acetonitrile (200 μL) to quench the enzymes and 100 μL of an internal 
standard solution (Silva et al., 2007) prepared with 13C2-PA, 13C4-MEHP, D4-MEOHP, D4-
MEHHP, and D4-MECPP in 10% aqueous acetonitrile. The contents in the microcentrifuge 
tubes were vortex mixed, and the tubes were stored at −70 °C. After the last sample was 
withdrawn, all samples were thawed at once and centrifuged at 12,500 rpm for 20 min. The 
supernatants were transferred into autosampler vials for analysis.
2.3. Identification of DEHTP metabolites
The HPLC gradient for separation of DEHTP metabolites and the on-line SPE procedure 
were adapted from previously published methods (Silva et al., 2007, 2013a). Briefly, 
metabolites in the supernatant of the human liver microsomal homogenate (500 μL) obtained 
after incubating with DEHTP for 5 h were extracted using on-line SPE on a Chromolith 
RP-18 pre-column (Merck KGaA, Darmstadt, Germany), resolved on a Betasil phenyl 
HPLC column (3 lM, 2.1 mm × 25 mm, ThermoFisher Scientific, San Jose, CA, USA) using 
a water/acetonitrile gradient, and detected by mass spectrometry on a TSQ Vantage AM 
triple quadrupole mass spectrometer (ThermoFinnigan, San Jose, CA, USA). All ions on Q1 
were scanned from m/z = 125 to m/z = 325 in electrospray ionization (ESI)-negative ion 
mode. ESI Q1 full scan produced multiple peaks. The fragmentation patterns of the major 
peaks were analyzed to identify potential DEHTP metabolites (Table 1). Metabolites unique 
to DEHTP (Fig. 1) were identified by comparing the mass transitions of the peaks resulting 
from human liver microsome incubate with DEHTP to those of human liver microsome 
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homogenate without DEHTP. Product ion scans were performed for major peaks, namely 
m/z = 165, 277, 291, 293, and 307.
2.4. Chromatographic separation and mass spectrometric detection of DEHP and DEHTP 
metabolites
DEHP and DEHTP metabolites were chromatographically separated and analyzed by mass 
spectrometry in negative ion, multiple reaction monitoring mode (Fig. 2) using a previously 
published approach (Silva et al., 2007, 2013a). DEHTP metabolites produced fragments 
with mass spectrometric transitions similar to those of the metabolites of DEHP (Figs. 3 and 
4). Therefore, to the supernatant of a human liver microsomal homogenate (500 μL) 
obtained after incubating 5 h with DEHTP, we added a solution containing five DEHP 
metabolites, namely PA, MEHHP, MEOHP, MECPP, and MEHP (100 μL, 50 ng/mL) to 
evaluate chromatographic separation of DEHTP metabolites in the presence of DEHP 
metabolites.
2.5. Comparison of major metabolites of DEHP and DEHTP
Product ion scans of the DEHTP metabolites identified tentatively (m/z = 165/121, 277/233, 
291/247, 293/121, and 307/121) in the human liver microsome homogenate after incubating 
with DEHTP were performed by injecting the supernatant of the microsomal homogenate 
(100 μL) to a Vantage AM triple quadrupole mass spectrometer after the HPLC separation 
described above. The procedure was repeated with a standard solution mixture (1 μg/mL) 
containing PA (m/z = 165/121), and the DEHP metabolites MEHP (m/z = 277/233), 
MEHHP (m/z = 293/121), MEOHP (m/ z = 291/247), and MECPP (m/z = 307/121). The 
comparison mass spectra are presented in Figs. 3 and 4.
2.6. Quantification of DEHTP and DEHP metabolites
The target metabolites from human liver microsomes homogenates incubated with DEHTP 
or DEHP for up to 27 h were measured by using on-line SPE–HPLC–tandem mass 
spectrometry as previously described (Silva et al., 2007, 2013a). The mobile phase 
contained 0.1% acetic acid in water and 0.1% acetic acid in acetonitrile. We did not attempt 
to characterize the individual isomers of MEHHTP or other DEHTP metabolites. PA, 
MEHP, MEHHP, MEHHTP, MEOHP, MECPP, and TPA were quantified using authentic 
standards. MEOHTP, and mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) were 
quantified using their corresponding isomeric DEHP metabolites (Table 1). The limits of 
detection (LODs) were 0.5 ng/mL (PA, TPA, MEHHTP, MEHP, MECPP) and 0.2 ng/mL 
(MEHHP, MEOHP).
3. Results and discussion
Metabolism of DEHTP using human liver microsomes (Fig. 1) formed analogous 
metabolites to those of DEHP. Full scan analysis in negative ion mode from m/z = 125 to 
m/z = 325 of the human liver microsomes supernatant after 5 h incubation with DEHTP 
resulted in multiple peaks (Fig. 2). Metabolites of DEHP, added post-incubation to the 
supernatant of the DEHTP microsomal homogenate, eluted earlier than their analogous 
DEHTP metabolites (Fig. 2). For DEHTP, we unambiguously identified TPA (m/z = 165, 
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retention time [RT] = 5.5 min) and three MEHHTP isomers (m/z = 293, RT = 15.5, 16.9 and 
18.6 min) using authentic standards, and tentatively identified MECPTP (m/z = 307, RT = 
16.7 min), MEOHTP (m/z = 291, RT = 19.9 min), and MEHTP (m/z = 277, RT = 25.7 min) 
using their mass spectrometric fragmentation patterns (Figs. 2–4). Isomers of MEHHTP 
with similar fragmentation patterns produced multiple chromatographic peaks between 15.5 
and 18.6 min (Fig. 2), and the fragmentation patterns of these isomers matched well with the 
fragmentation of the MEHHTP authentic standard (Fig. 4). The potential for multiple sites 
of oxidation also exists for MEOHTP, but MEOHTP eluted as a single broad peak at 19.9 
min. We could not determine conclusively whether multiple isomers of MEOHTP co-eluted 
or the in vitro metabolism of DEHTP produced only one isomer of MEOHTP.
DEHTP and DEHP metabolites displayed different fragmentation patterns. The mass spectra 
of the hydrolytic metabolites TPA and PA, and of MEHTP and MEHP are presented in Fig. 
3, whereas those of the oxidative metabolites MEHHP and MEHHTP, MECPP and 
MECPTP, and MEOHP and MEOHTP are presented in Fig. 4. The major m/z transition for 
TPA, MEHHTP, and MECPTP was m/z = 121  at 25 eV collision energy. Under 
similar conditions, the most abundant fragments for MEHTP (Fig. 3B) and for MEOHTP 
(Fig. 4C) were m/z = 233 [(M-1)-CO2]− and m/z = 247 [(M-1)-CO2]−, respectively. DEHP 
metabolites, MEHHP and MEOHP also produced m/z 121 as their major fragment (Fig. 4). 
The major fragments of the other DEHP metabolites were m/z = 77 (PA), m/z = 134 
(MEHP), and m/ z = 159 (MECPP).
We also evaluated the in vitro metabolism of DEHP and DEHTP for up to 27 h (Fig. 5) and 
noted that the metabolic profile of DEHTP and DEHP differed significantly (Table 2). 
DEHTP formed MEHTP, MEOHTP, MEHHTP, MECPTP, and TPA which are analogous to 
the DEHP metabolites MEHP, MEOHP, MEHHP, MECPP, and PA, respectively. TPA was 
the major metabolite of DEHTP, whereas DEHP mainly hydrolyzed to MEHP, which 
further metabolized to MEHHP, MEOHP, MECPP, and PA (Table 2). MECPTP was 
produced only as a minor in vitro metabolite of DEHTP. Interestingly, the in vitro 
metabolism of DEHP produced MECPP as a minor metabolite, but MECPP is one of the 
major DEHP urinary metabolites in humans (Koch et al., 2003; Silva et al., 2007). Similarly, 
the fraction of DEHTP excreted as MECPTP and other oxidative metabolites may be higher 
in vivo than in vitro, thus warranting further investigations.
In summary, using human liver microsomes, we unequivocally identified TPA as the major 
in vitro metabolite of DEHTP and MEHHTP as one specific metabolite of DEHTP. We also 
tentatively identified three unique metabolites of DEHTP, specifically MEHTP, MEOHTP, 
and MECPTP. TPA can be formed by other terephthalates (e.g., di-methyl terephthalate) 
and, therefore, is not a specific biomarker of exposure to DEHTP. In contrast, MEHTP, 
MEOHTP, MEHHTP, and MECPTP may serve as specific exposure biomarkers of DEHTP. 
Nonetheless, additional considerations, such as adequate collection protocols, handling and 
storage of the samples, and data on the urinary excretion fraction and temporal stability of 
these metabolites in urine, are needed to demonstrate the utility of these biomarkers for 
exposure or risk assessment purposes.
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Metabolic products tentatively identified in the supernatant of the human liver microsome 
suspension after incubating with di-2-ethylhexyl terephthalate for 5 h.
*The structures shown for MEOHTP and MEHHTP are for one isomer only.
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Chromatographic separation of di-2-ethylhexyl phthalate and di-2-ethylhexyl terephthalate 
metabolites detected in the supernatant of the human liver microsomes suspension of 
DEHTP after 5 h incubation at 37 °C and spiked with DEHP metabolites.
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Comparison of mass spectrometric fragmentation of hydrolytic metabolites of DEHTP and 
DEHP: TPA and PA (A), MEHTP and MEHP (B).
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Mass spectrometric fragmentation of oxidative metabolites of DEHTP. MEHHTP and 
MEHHP (A), MEHHTP standard (A′), MECPTP and MECPP (B), and MEOHP and 
MEOHTP (C).
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In vitro metabolism of DEHP (A) and DEHTP (B) with human liver microsomes. Error bars 
represent standard deviation. N = 3, TPA, MECPTP, MEHTP and MEOHTP were 
quantified using analogous phthalate metabolites.
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Table 1




Terephthalic acid (TPA) 165 121
Mono-2-ethylhexyl terephthalate (MEHTP) 277 233
Mono-2-ethylhydroxyhexyl terephthalate (MEHHTP) 293 121
Mono-2-ethyloxohexyl terephthalate (MEOHTP) 291 247
Mono-2-ethylcarboxypentyl terephthalate (MECPTP) 307 121
a
Collision energy was 25 eV.
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Table 2
Concentration of DEHTP and DEHP metabolites (N = 3) after incubating 640 nmoles of DEHTP and DEHP 









TPA 27.2 ± 1.17 PA 0.93 ± 0.02
MEHTP 0.06 ± 0.003 MEHP 44.44 ± 1.76
MEHHTP 2.43 ± 0.10 MEHHP 12.84 ± 0.58
MEOHTP 0.17 ± 0.01 MEOHP 0.14 ± 0.01
MECPTP 0.06 ± 0.01 MECPP 0.18 ± 0.01
Terephthalic acid (TPA), mono-2-ethyloxohexyl terephthalate (MEOHTP), mono-2-ethylhydroxyhexyl terephthalate (MEHHTP), mono-2-
ethylhexyl terephthalate (MEHTP), mono-2-ethylcarboxypentyl terephthalate (MECPTP), Phthalic acid (PA), mono-2-ethyl-5-oxohexylphthalate 
(MEOHP), mono-2-ethyl-5-hydroxyhexyl phthalate (MEHHP), mono-2-ethyl-5-carboxypentyl phthalate (MECPP), mono-2-ethylhexyl phthalate 
(MEHP).
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